Franklin Resources Inc Acadia Pharmaceuticals Inc Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 188,965 shares of ACAD stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

188,965

Previous 188,965 -0.0%

Holding current value

$3.23 Million

Previous $2.91 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $3,436 - $4,344	-227 Reduced 0.12%	188,965 $2.91 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $595,194 - $749,896	40,711 Added 27.42%	189,192 $3.07 Million
Q1 2024 May 13, 2024	BUY	$17.79 - $30.86 $1.74 Million - $3.03 Million	98,076 Added 194.58%	148,481 $2.75 Million
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $16,686 - $25,511	803 Added 1.62%	50,405 $1.58 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $45,806 - $73,567	2,198 Added 4.64%	49,602 $1.03 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $295,088 - $425,225	16,578 Added 53.78%	47,404 $1.14 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $8,241 - $10,564	-505 Reduced 1.61%	30,826 $580,000
Q4 2022 Feb 10, 2023	SELL	$14.2 - $18.63 $6,191 - $8,122	-436 Reduced 1.37%	31,331 $498,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $236,130 - $305,748	16,735 Added 111.33%	31,767 $520,000
Q2 2022 Aug 11, 2022	SELL	$13.01 - $27.22 $40,122 - $83,946	-3,084 Reduced 17.02%	15,032 $212,000
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $28,645 - $37,620	1,368 Added 8.17%	18,116 $439,000
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $281,198 - $453,703	16,748 New	16,748 $391,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $11.2 Million - $17.6 Million	-711,711 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $39,711 - $56,128	2,047 Added 0.29%	711,711 $17.4 Million
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $19,215 - $42,232	-768 Reduced 0.11%	709,664 $18.3 Million
Q4 2020 Feb 10, 2021	BUY	$41.04 - $56.79 $25,732 - $35,607	627 Added 0.09%	710,432 $38 Million
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $1.21 Million - $1.89 Million	33,215 Added 4.91%	709,805 $29.3 Million
Q4 2019 Feb 12, 2020	SELL	$36.21 - $51.4 $2.65 Million - $3.76 Million	-73,200 Reduced 9.76%	676,590 $28.9 Million
Q1 2019 May 14, 2019	BUY	$16.17 - $27.38 $11.6 Million - $19.7 Million	719,396 Added 2366.9%	749,790 $20.1 Million
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $435,242 - $696,630	30,394 New	30,394 $491,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $32.6 Million - $48.4 Million	-2,166,346 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$22.47 - $32.33 $24.1 Million - $34.6 Million	-1,071,500 Reduced 33.09%	2,166,346 $48.7 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $4.54 Million - $6.62 Million	169,057 Added 5.51%	3,237,846 $97.5 Million
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $90.5 Million - $118 Million	3,068,789	3,068,789 $116 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Acadia Pharmaceuticals Inc Transaction History